It is hoped that more patients would have early access to new medication therapies, care, and support.
About 5,000 participants will be involved in the University of Oxford and University College London research.
The five-year experiment will investigate blood testing for dementia, including Alzheimer’s disease and other types.
Nowadays, roughly one-third of dementia patients are left feeling anxious and uneasy about their health since they never receive a formal diagnosis.
aberrant proteins
Merely 2% of patients have one of the “gold standard” diagnostics for Alzheimer’s disease, which is a spinal lumbar puncture or a specialized brain scan.
